Related content

Safety and efficacy of temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma

By Lamm Wolfgang   Vogl Ursula Maria   Bojic Marija   Zielinski Christoph   Klingler Christoph   Kramer Gero   Schmidinger Manuela  

Acta Oncologica, Vol. 51, Iss. 1, 2012-01 ,pp. : 101-106

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma

By Kim Ki   Yoon Sang   Lee Hae-Jung   Kim Hyo   Shin Sang   Ahn Joong   Rha Sun  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 853-860

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life in Japanese patients with metastatic renal cell carcinoma treated with sunitinib

By Miyake Hideaki  

International Journal of Clinical Oncology, Vol. 18, Iss. 2, 2013-04 ,pp. : 220-225

Springer Publishing Company

Access to resources Recommend Favorite

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

By Naito Seiji   Tsukamoto Taiji   Usami Michiyuki   Fujimoto Hiroyuki   Akaza Hideyuki  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1065-1070

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma with and without prior cytokine therapy, a subanalysis of TARGET

By Negrier S.   Jäger E.   Porta C.   McDermott D.   Moore M.   Bellmunt J.   Anderson S.   Cihon F.   Lewis J.   Escudier B.   Bukowski R.  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 899-906

Humana Press, Inc

Access to resources Recommend Favorite